durvalumab,pembrolizumab,cisplatin,gemcitabine
merck,astrazeneca
['kn-966', '$mrk']
stat-sig os &amp; non-stat sig pfs curves from $mrk kn-966, and the puzzling orr result showing no difference vs chemo alone, via katie kelley #aacr23 
Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.